Summit Therapeutics PLC (SMMT) — Cash Flow Reinvestment Rate
Summit Therapeutics PLC (SMMT) has a Cash Flow Reinvestment Rate of 152.67x as of December 2022, reinvesting $646.06 Million (capex $994.38K plus investments $-645.06 Million) from operating cash flow of $4.23 Million. Explore SMMT capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Summit Therapeutics PLC Cash Flow Reinvestment Rate (2004–2016)
Historical reinvestment intensity for Summit Therapeutics PLC across 2 annual periods. Also explore how large is Summit Therapeutics PLC's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Summit Therapeutics PLC (2004–2016)
Year-by-year capital reinvestment analysis for Summit Therapeutics PLC. For live market cap and broader valuation context, see market cap of Summit Therapeutics PLC.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.01x | $209.99K | $15.18 Million | $110.00K | ▼ -94.1% |
| 2004 | 0.23x | $13.18K | $56.48K | $13.18K | — |